Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA. - Taniguchi Y; Tamiya A; Osuga M; Isa SI; Nakamura K; Mizumori Y; Shinohara T; Yanai H; Nakatomi K; Oki M; Mori M; Kuwako T; et al. (Investigational new drugs, 2025)